Literature DB >> 16845274

Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.

Santhosh Girirajan1, Christopher N Vlangos, Barbara B Szomju, Emily Edelman, Christopher D Trevors, Lucie Dupuis, Marjan Nezarati, David J Bunyan, Sarah H Elsea.   

Abstract

PURPOSE: Smith-Magenis syndrome (SMS) is a complex disorder that includes mental retardation, craniofacial and skeletal anomalies, and behavioral abnormalities. We report the molecular and genotype-phenotype analyses of 31 patients with SMS who carry 17p11.2 deletions or mutations in the RAI1 gene.
METHODS: Patients with SMS were evaluated by fluorescence in situ hybridization and/or sequencing of RAI1 to identify 17p11.2 deletions or intragenic mutations, respectively, and were compared for 30 characteristic features of this disorder by the Fisher exact test.
RESULTS: In our cohort, 8 of 31 individuals carried a common 3.5 Mb deletion, whereas 10 of 31 individuals carried smaller deletions, two individuals carried larger deletions, and one individual carried an atypical 17p11.2 deletion. Ten patients with nondeletion harbored a heterozygous mutation in RAI1. Phenotypic comparison between patients with deletions and patients with RAI1 mutations show that 21 of 30 SMS features are the result of haploinsufficiency of RAI1, whereas cardiac anomalies, speech and motor delay, hypotonia, short stature, and hearing loss are associated with 17p11.2 deletions rather than RAI1 mutations (P<.05). Further, patients with smaller deletions show features similar to those with RAI1 mutations.
CONCLUSION: Although RAI1 is the primary gene responsible for most features of SMS, other genes within 17p11.2 contribute to the variable features and overall severity of the syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845274     DOI: 10.1097/01.gim.0000228215.32110.89

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  46 in total

1.  Smith-Magenis Syndrome: Face Speaks.

Authors:  Rekha Gupta; Neerja Gupta; Sheela Nampoothiri; Kausik Mandal; Yougal Kishore; Pankaj Sharma; Madhulika Kabra; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2015-12-17       Impact factor: 1.967

2.  Rare copy number variation in cerebral palsy.

Authors:  Gai McMichael; Santhosh Girirajan; Andres Moreno-De-Luca; Jozef Gecz; Chloe Shard; Lam Son Nguyen; Jillian Nicholl; Catherine Gibson; Eric Haan; Evan Eichler; Christa Lese Martin; Alastair MacLennan
Journal:  Eur J Hum Genet       Date:  2013-05-22       Impact factor: 4.246

3.  Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.

Authors:  Jiong Yan; Weimin Bi; James R Lupski
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

4.  Abnormal circadian rhythm of melatonin in Smith-Magenis syndrome patients with RAI1 point mutations.

Authors:  Philip M Boone; Russel J Reiter; Daniel G Glaze; Dun-Xian Tan; James R Lupski; Lorraine Potocki
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

5.  Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder.

Authors:  Michael E Talkowski; Sureni V Mullegama; Jill A Rosenfeld; Bregje W M van Bon; Yiping Shen; Elena A Repnikova; Julie Gastier-Foster; Devon Lamb Thrush; Sekar Kathiresan; Douglas M Ruderfer; Colby Chiang; Carrie Hanscom; Carl Ernst; Amelia M Lindgren; Cynthia C Morton; Yu An; Caroline Astbury; Louise A Brueton; Klaske D Lichtenbelt; Lesley C Ades; Marco Fichera; Corrado Romano; Jeffrey W Innis; Charles A Williams; Dennis Bartholomew; Margot I Van Allen; Aditi Parikh; Lilei Zhang; Bai-Lin Wu; Robert E Pyatt; Stuart Schwartz; Lisa G Shaffer; Bert B A de Vries; James F Gusella; Sarah H Elsea
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

6.  Whole exome sequencing identifies RAI1 mutation in a morbidly obese child diagnosed with ROHHAD syndrome.

Authors:  Vidhu V Thaker; Kristyn M Esteves; Meghan C Towne; Catherine A Brownstein; Philip M James; Laura Crowley; Joel N Hirschhorn; Sarah H Elsea; Alan H Beggs; Jonathan Picker; Pankaj B Agrawal
Journal:  J Clin Endocrinol Metab       Date:  2015-03-17       Impact factor: 5.958

7.  Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.

Authors:  Stephen R Williams; Sureni V Mullegama; Jill A Rosenfeld; Aditi I Dagli; Eli Hatchwell; William P Allen; Charles A Williams; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2009-11-11       Impact factor: 4.246

8.  Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response.

Authors:  Santhosh Girirajan; Paula M Hauck; Stephen Williams; Christopher N Vlangos; Barbara B Szomju; Sara Solaymani-Kohal; Philip D Mosier; Kimber L White; Kathleen McCoy; Sarah H Elsea
Journal:  Mamm Genome       Date:  2008-03-15       Impact factor: 2.957

Review 9.  Frameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literature.

Authors:  Hoa T Truong; Tracy Dudding; Christopher L Blanchard; Sarah H Elsea
Journal:  BMC Med Genet       Date:  2010-10-08       Impact factor: 2.103

10.  Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Carolina A Encina; Cesar P Canales; Lei Cao; Jessica Molina; Pamela Kairath; Juan I Young; Katherina Walz
Journal:  BMC Mol Biol       Date:  2010-08-25       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.